ScholarIQanswers from OpenAlex & ORCID
Peter B. Gilbert
ResearcherPublications, citations & collaboration network
Peter B. Gilbert is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Peter B. Gilbert have?
ScholarIQindexed works
Peter B. Gilbert has 601 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Peter B. Gilbert have?
ScholarIQcitation count
Peter B. Gilbert has 32,351 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Peter B. Gilbert?
ScholarIQh-index
Peter B. Gilbert has an h-index of 81 in OpenAlex.
What is the i10-index of Peter B. Gilbert?
ScholarIQi10-index
Peter B. Gilbert has an i10-index of 327 in OpenAlex.
What is the ORCID of Peter B. Gilbert?
ScholarIQorcid
The ORCID for Peter B. Gilbert is on the source record.
What is the OpenAlex record for Peter B. Gilbert?
ScholarIQopenalex
The OpenAlex for Peter B. Gilbert is on the source record.
What are the most-cited papers on Peter B. Gilbert?
ScholarIQmost cited works
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
Susan Buchbinder, Devan V. Mehrotra, Ann Duerr, Daniel W. Fitzgerald, Robin Mogg, David Li, Peter B. Gilbert, Javier R. Lama, Michael Marmor, Carlos del Rı́o, M. Juliana McElrath, Danilo R. Casimiro, Keith Gottesdiener, Jeffrey Chodakewitz, Lawrence Corey, Michael Robertson
Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial
Peter B. Gilbert, David C. Montefiori, Adrian B. McDermott, Youyi Fong, David Benkeser, Weiping Deng, Honghong Zhou, Christopher R. Houchens, Karen Martins, Lakshmi Jayashankar, Flora Castellino, Britta Flach, Bob C. Lin, Sarah O’Connell, Charlene McDanal, Amanda Eaton, Marcella Sarzotti‐Kelsoe, Yiwen Lu, Chenchen Yu, Bhavesh Borate, Lars W. P. van der Laan, Nima S. Hejazi, Chuong Huynh, Jacqueline M. Miller, Hana M. El Sahly, Lindsey R. Baden, Mira Baron, Luis de la Cruz‐Merino, Cynthia L. Gay, Spyros A. Kalams, Colleen F. Kelley, Michele P. Andrasik, James G. Kublin, Lawrence Corey, Kathleen M. Neuzil, Lindsay N. Carpp, Rolando Pajón, Dean Follmann, Rubén O. Donis, Richard A. Koup, Immune Assays Team§, Coronavirus Vaccine Prevention Network (CoVPN)/Coronavirus Efficacy (COVE) Team§, United States Government (USG)/CoVPN Biostatistics Team§
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase
Hana M. El Sahly, Lindsey R. Baden, Brandon Essink, Susanne Doblecki‐Lewis, Judith M. Martin, Evan J. Anderson, Thomas Campbell, Jesse L. Clark, Lisa A. Jackson, Carl J. Fichtenbaum, Marcus Zervos, Bruce Rankin, Frank Eder, Gregory Feldman, C Kennelly, Laurie J. Han-Conrad, Michael Levin, Kathleen M. Neuzil, Lawrence Corey, Peter B. Gilbert, Holly Janes, Dean Follmann, Mary Marovich, Laura Polakowski, John R. Mascola, Julie E. Ledgerwood, Barney S. Graham, Allison August, Heather Clouting, Weiping Deng, Shu Han, Brett Leav, Deb Manzo, Rolando Pajón, F. Schödel, Joanne E. Tomassini, Honghong Zhou, Jacqueline M. Miller
Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition
Lawrence Corey, Peter B. Gilbert, Michal Juraska, David C. Montefiori, Lynn Morris, Shelly Karuna, Srilatha Edupuganti, Nyaradzo Mgodi, Allan C. deCamp, Erika Rudnicki, Yunda Huang, Pedro Gonzáles, Robinson Cabello, Catherine Orrell, Javier R. Lama, Fatima Laher, Erica Lazarus, Jorge Sánchez, Ian Frank, Juan Hinojosa, Magdalena E. Sobieszczyk, Kyle Marshall, Pamela Mukwekwerere, Joseph Makhema, Lindsey R. Baden, James I. Mullins, Carolyn Williamson, John Hural, M. Juliana McElrath, Carter Bentley, Simbarashe Takuva, Margarita M. Gomez Lorenzo, David Burns, Nicole Espy, April K. Randhawa, Nidhi Kochar, Estelle Piwowar‐Manning, Deborah Donnell, Nirupama Sista, P. Andrew, James G. Kublin, Glenda Gray, Julie E. Ledgerwood, John R. Mascola, Myron S. Cohen